We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cost-effectiveness of maraviroc for antiretroviral treatment-experienced HIV-infected individuals in Mexico.
- Authors
Contreras-Hernandez, Iris; Becker, Debbie; Chancellor, Jeremy; Kühne, Felicitas; Mould-Quevedo, Joaquin; Vega, Gabriela; Marfatia, Shalaka
- Abstract
Maraviroc is the first approved drug in a new class of antiretrovirals, the CCR5 antagonists. The objective of this study was to predict the long-term clinical impact and cost-effectiveness of maraviroc in treatment-experienced adults with HIV/AIDS in Mexico.
- Publication
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2010, Vol 13, Issue 8, p903
- ISSN
1524-4733
- Publication type
Journal Article
- DOI
10.1111/j.1524-4733.2010.00798.x